1. Home
  2. ATS vs BLTE Comparison

ATS vs BLTE Comparison

Compare ATS & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATS
  • BLTE
  • Stock Information
  • Founded
  • ATS 1978
  • BLTE 2018
  • Country
  • ATS Canada
  • BLTE United States
  • Employees
  • ATS N/A
  • BLTE N/A
  • Industry
  • ATS
  • BLTE Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATS
  • BLTE Health Care
  • Exchange
  • ATS Nasdaq
  • BLTE Nasdaq
  • Market Cap
  • ATS 2.5B
  • BLTE 2.1B
  • IPO Year
  • ATS 2023
  • BLTE 2022
  • Fundamental
  • Price
  • ATS $26.07
  • BLTE $79.50
  • Analyst Decision
  • ATS
  • BLTE Strong Buy
  • Analyst Count
  • ATS 0
  • BLTE 4
  • Target Price
  • ATS N/A
  • BLTE $96.00
  • AVG Volume (30 Days)
  • ATS 93.3K
  • BLTE 67.7K
  • Earning Date
  • ATS 11-28-2025
  • BLTE 11-11-2025
  • Dividend Yield
  • ATS N/A
  • BLTE N/A
  • EPS Growth
  • ATS N/A
  • BLTE N/A
  • EPS
  • ATS N/A
  • BLTE N/A
  • Revenue
  • ATS $1,886,061,785.00
  • BLTE N/A
  • Revenue This Year
  • ATS $17.99
  • BLTE N/A
  • Revenue Next Year
  • ATS $5.49
  • BLTE N/A
  • P/E Ratio
  • ATS N/A
  • BLTE N/A
  • Revenue Growth
  • ATS N/A
  • BLTE N/A
  • 52 Week Low
  • ATS $20.90
  • BLTE $49.00
  • 52 Week High
  • ATS $33.13
  • BLTE $86.53
  • Technical
  • Relative Strength Index (RSI)
  • ATS 42.25
  • BLTE 70.69
  • Support Level
  • ATS $25.35
  • BLTE $76.50
  • Resistance Level
  • ATS $27.18
  • BLTE $80.00
  • Average True Range (ATR)
  • ATS 0.70
  • BLTE 2.34
  • MACD
  • ATS -0.03
  • BLTE 0.53
  • Stochastic Oscillator
  • ATS 31.10
  • BLTE 94.28

About ATS ATS Corporation

ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: